Some of the evidence demonstrated that GRP78 level in plasma may correlate with the disease stage, as plasma GRP78 was found higher in late-stage non-small cell lung cancer patients compared to an early stage53, then GRP78 might be one of a good candidate for a novel prognostic marker for lung cancer. Here, HSPA5 is linked to non-small cell lung carcinoma.